Clominorex

From Food & Medicine Encyclopedia

Clominorex


Clominorex is a psychostimulant and anorectic drug that was patented and developed by the pharmaceutical company Yamanouchi Pharmaceutical. It is related to other anorectic agents such as fenfluramine and chlorphentermine.

History[edit]

Clominorex was first synthesized and patented in the 1960s by Yamanouchi Pharmaceutical. It was developed as a potential treatment for obesity due to its anorectic properties. However, it was never marketed and remains a largely obscure compound.

Pharmacology[edit]

Clominorex is a norepinephrine-dopamine reuptake inhibitor and releasing agent. It is structurally related to other anorectic agents such as fenfluramine and chlorphentermine, which are also norepinephrine-dopamine reuptake inhibitors. However, unlike these drugs, clominorex does not have any serotonin releasing activity.

Legal Status[edit]

Clominorex is not currently approved for medical use in any country. It is classified as a Schedule I controlled substance in the United States under the Controlled Substances Act, meaning it has a high potential for abuse and no accepted medical use.

See Also[edit]

References[edit]

<references />

This article is a stub related to pharmacology. You can help WikiMD by expanding it!

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.